Pharmacotherapy

Article	Citations
Remdesivir: Review of Pharmacology, Pre‐clinical Data, and Emerging Clinical Experience for COVID‐19	187
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019	150
Baricitinib: A Review of Pharmacology, Safety, and Emerging Clinical Experience in COVID‐19	135
COVID‐19 Clinical Diagnostics and Testing Technology	99
Therapeutic Potential for Tetracyclines in the Treatment of COVID‐19	86
Considerations for Statin Therapy in Patients with COVID‐19	78
Managing COVID‐19 in Renal Transplant Recipients: A Review of Recent Literature and Case Supporting Corticosteroid‐sparing Immunosuppression	67
A guide to therapeutic drug monitoring of β‐lactam antibiotics	61
Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management	58
Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID‐19	54
Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections	52
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin‐Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of H	50
Delayed Initiation of Remdesivir in a COVID‐19‐Positive Patient	48
Vancomycin‐Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention	45
Acetylcysteine for the Treatment of Suspected Remdesivir‐Associated Acute Liver Failure in COVID‐19: A Case Series	43
Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective	33
Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the I	33
Advantages of Outpatient Treatment with Long‐Acting Lipoglycopeptides for Serious Gram‐Positive Infections: A Review	28
Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug‐Resistant Gram‐Negative Pathogens	28
Drug‐Induced Ototoxicity: A Comprehensive Review and Reference Guide	26
Meta‐analysis of clinical outcomes of PCSK9 modulators in patients with established ASCVD	26
Model‐Based Analysis of Cannabidiol Dose‐Exposure Relationship and Bioavailability	26
Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis	25
An Overview of the Treatment of Less Common Non–Lactose‐Fermenting Gram‐Negative Bacteria	24
Approach to the Treatment of Patients with Serious Multidrug‐Resistant Pseudomonas aeruginosa Infections	23

Optimizing anticoagulation for patients receiving Impella support	22
Chloroquine and Hydroxychloroquine in the Era of SARS – CoV2: Caution on Their Cardiac Toxicity	22
CYP2D6 Genetic Polymorphisms and Risperidone Pharmacokinetics: A Systematic Review and Meta‐analysis	21
Treatment of patients with serious infections due to carbapenem‐resistant Acinetobacter baumannii: How viable are the current options?	21
Role of maternal COVID‐19 vaccination in providing immunological protection to the newborn	21
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review	21
Comparison of high‐dose dual therapy with bismuth‐containing quadruple therapy in Helicobacter pylori‐infected treatment‐naive patients: An open‐label, multicenter, randomized controlled trial	20
Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of clinical studies	19
Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso‐occlusive Pain Crises in Patients with Sickle Cell Disease	19
Antipsychotic Medications and DNA Methylation in Schizophrenia and Bipolar Disorder: A Systematic Review	19
Analgesia and Sedation Strategies in Mechanically Ventilated Adults with COVID‐19	18
Emerging therapies for the treatment of nonalcoholic steatohepatitis: A systematic review	18
Akathisia and Newer Second‐Generation Antipsychotic Drugs: A Review of Current Evidence	18
Effect of Preinjury Oral Anticoagulants on Outcomes Following Traumatic Brain Injury from Falls in Older Adults	18
Combination of Vancomycin or Daptomycin and Beta‐lactam Antibiotics: A Meta‐analysis	17
CBD and THC: Do They Complement Each Other Like Yin and Yang?	17
Systematic Review of Voxelotor: A First‐in‐Class Sickle Hemoglobin Polymerization Inhibitor for Management of Sickle Cell Disease	17
Scoping review of augmented renal clearance in critically ill pediatric patients	16
Antibiotics in the Biliary Tract: A Review of the Pharmacokinetics and Clinical Outcomes of Antibiotics Penetrating the Bile and Gallbladder Wall	16
Association of proton pump inhibitor use with endothelial function and metabolites of the nitric oxide pathway: A cross‐sectional study	15
Risk of Venous Thromboembolism Associated With Tofacitinib and Baricitinib: A Systematic Review and Indirect Meta‐Analysis	15
Use of direct‐acting oral anticoagulants in solid organ transplantation: A systematic review	15
Gut microbiome health and dysbiosis: A clinical primer	14
Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability	14
Cisplatin‐induced nephrotoxicity in an outpatient setting	14
Therapeutic review of cabotegravir/rilpivirine long‐acting antiretroviral injectable and implementation considerations at an HIV specialty clinic	14
Comparison of Hydromorphone versus Fentanyl‐based Sedation in Extracorporeal Membrane Oxygenation: A Propensity‐Matched Analysis	13
Nephrotoxicity Risk and Clinical Effectiveness of Continuous versus Intermittent Infusion Vancomycin Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program	13
DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation	13
Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline	13
Physiologically based pharmacokinetic modeling of tramadol to inform dose adjustment and drug‐drug interactions according to CYP2D6 phenotypes	13
Alopecia signals associated with calcitonin gene‐related peptide inhibitors in the treatment or prophylaxis of migraine: A pharmacovigilance study	12
Comparison of Body Size, Morphomics, and Kidney Function as Covariates of High‐Dose Methotrexate Clearance in Obese Adults with Primary Central Nervous System Lymphoma	12
Bamlanivimab use in mild‐to‐moderate COVID‐19 disease: A matched cohort design	12
Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta‐analysis	12
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents	12
Multi‐center retrospective study evaluating the efficacy and safety of apixaban versus warfarin for treatment of venous thromboembolism in patients with severe obesity	11
Tebipenem pivoxil hydrobromide—No PICC, no problem!	11
Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID‐19): A systematic review	11
Advances in CAR T Therapy for Hematologic Malignancies	11
The impact of statin use prior to intensive care unit admission on critically ill patients with sepsis	11
Long‐term Follow‐up of Hematopoietic Stem Cell Transplant Survivors: A Focus on Screening, Monitoring, and Therapeutics	11
Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients	11
Prescription Medication Use in Older Adults Without Major Cardiovascular Disease Enrolled in the Aspirin in Reducing Events in the Elderly (ASPREE) Clinical Trial	11
Combining Antidepressants with β‐Blockers: Evidence of a Clinically Significant CYP2D6 Drug Interaction	11
The association between urate‐lowering therapies and treatment‐related adverse events, liver damage, and major adverse cardiovascular events (MACE): A network meta‐analysis of randomized trials	11
Poor tolerability of cystic fibrosis transmembrane conductance regulator modulator therapy in lung transplant recipients	11
Use of psychiatric medication by college students: A decade of data	11
Evolving Therapeutic Options for Chronic Graft‐versus‐Host Disease	11
A systematic review of the drug–drug interaction between statins and colchicine: Patient characteristics, etiologies, and clinical management strategies	11

Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease	10
Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS‐C) associated with	10
Reduced alternative insulin dosing in hyperkalemia: A meta‐analysis of effects on hypoglycemia and potassium reduction	10
Omega‐3 fatty acids for the prevention of atherosclerotic cardiovascular disease	10
Prophylactic norepinephrine infusion for postspinal anesthesia hypotension in patients undergoing cesarean section: A randomized, controlled, dose‐finding trial	10
Optimization of Vancomycin Dosing Regimen in Cancer Patients using Pharmacokinetic/Pharmacodynamic Modeling	10
Hydroxychloroquine in Hospitalized Patients with COVID‐19: Real‐World Experience Assessing Mortality	10
Comparison of Bayesian‐derived and first‐order analytic equations for calculation of vancomycin area under the curve	10
Anticholinergic medication burden and cognitive function in participants of the ASPREE study	10
Myocardial infarction associated with erenumab: A case report	10
Achievement of goal anti‐Xa activity with weight‐based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients	10
Methadone‐associated QT interval prolongation in patients undergoing maintenance therapy in an urban opioid treatment program	9
Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care	9
Using l‐Carnitine as a Pharmacologic Probe of the Interpatient and Metabolic Variability of Sepsis	9
Systematic review and meta‐analysis of the correlation between bispectral index (BIS) and clinical sedation scales: Toward defining the role of BIS in critically ill patients	9
Response to intravenous racemic ketamine after switch from intranasal (S)‐ketamine on symptoms of treatment‐resistant depression and post‐traumatic stress disorder in Veterans: A retrospective case se	8
Using Child‐Pugh Class to Optimize Voriconazole Dosage Regimens and Improve Safety in Patients with Liver Cirrhosis: Insights from a Population Pharmacokinetic Model‐based Analysis	8
Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation	8
Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non‐Fulminant Severe Clostridioides difficile Infection	8
Systematic review of drug–drug interactions between rifamycins and anticoagulant and antiplatelet agents and considerations for management	8
Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–2016	8
Pneumococcal vaccination—A literature review and practice guideline update	8
Apixaban and rivaroxaban use for atrial fibrillation in patients with obesity and BMI ≥50 kg/m2	8
Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists	8
Safety and efficacy of a platelet glycoprotein Ib inhibitor for patients with non‐ST segment elevation myocardial infarction: A phase Ib/IIa study	8
A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the	8
Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: Mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series	8
Glucagon: Its evolving role in the management of hypoglycemia	8
Immunosuppression considerations in simultaneous organ transplant	7
Lack of drug interaction between levetiracetam and high‐dose methotrexate in patients with lymphoma	7
Differences in Predicted Warfarin Dosing Requirements Between Hmong and East Asians Using Genotype‐Based Dosing Algorithms	7
Effects of β2‐Adrenergic Agonists on Risk of Parkinson's Disease in COPD: A Population‐Based Study	7
Treprostinil Attains Clinically Therapeutic Concentrations in Neonates with Pulmonary Hypertension on Extracorporeal Membrane Oxygenation Support	7
National Trends in Oral Antibiotic Prescribing in United States Physician Offices from 2009 to 2016	7
A Systematic Review and Meta‐Analysis of Metolazone Compared to Chlorothiazide for Treatment of Acute Decompensated Heart Failure	7
Molecular Adsorbent Recirculating System Therapy with Continuous Renal Replacement Therapy Enhanced Clearance of Piperacillin in a Pediatric Patient and Led to Failure to Attain Pharmacodynamic Target	7
Systematic literature review of insulin dose adjustments when initiating hemodialysis or peritoneal dialysis	7
Intensive Care Unit Delirium in Surgical Patients Is Associated with Upregulation in Tryptophan Metabolism	7
Population pharmacokinetic model‐guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction	7
Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review	7
The role of inflammation in the pathogenesis and treatment of arrhythmias	7
Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy	7
TheMPRINTHub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal–pediatric therapeutics research through data integration and pharmacometrics	7
A retrospective analysis of bleeding risk with rivaroxaban, enoxaparin, and aspirin following total joint arthroplasty or revision	7
Successful prolonged treatment of a carbapenem‐resistant Acinetobacter baumannii hip infection with cefiderocol: A case report	7
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists	7
Factors influencing antibiotic duration in culture‐negative neonatal early‐onset sepsis	6
Melatonin Use in Hospitalized Children for Non‐Anesthetic Indications: A Systematic Review	6
Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low‐Efficiency Dialysis	6
Modeling Kinetic Glomerular Filtration Rate in Adults with Stable and Unstable Kidney Function: Vancomycin as the Motivating Example	6
Precision‐based approaches to delirium in critical illness: A narrative review	6
Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures	6
NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo‐DHF trial	6
Enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in renally impaired ICU patients	6
Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired‐hepatic function	6
Evaluation of dosing strategies and trough concentrations of vancomycin in patients undergoing continuous venovenous hemofiltration	6
Predicting Interactions between Rifampin and Antihypertensive Drugs Using the Biopharmaceutics Drug Disposition Classification System	6
Adequacy of cefepime concentrations in the early phase of critical illness: A case for precision pharmacotherapy	6
Low‐dose versus standard‐dose four‐factor prothrombin complex concentrate for factor‐Xa inhibitor reversal in spontaneous and traumatic intracranial hemorrhage	6
Pharmacotherapy for durable left ventricular assist devices	6
TT genotype of the MMP‐9‐1562C/T polymorphism may be a risk factor for thrombolytic therapy‐induced hemorrhagic complications after acute ischemic stroke	6
Advances in the treatment of transthyretin cardiac amyloidosis: Current and emerging therapies	6
First‐Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area‐Under‐the‐Curve Target Attainment in Critically Ill Patients	6
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study	6
Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections	6
Advances in personalized medicine and noninvasive diagnostics in solid organ transplantation	6
Patient risk factors for opioid‐related adverse drug events in hospitalized patients: A systematic review	6
COVID‐19: The Uninvited Guest in the Intensive Care Unit — Implications for Pharmacotherapy	6
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review	6
Potentially Inappropriate Medication Combination with Opioids among Older Dental Patients: A Retrospective Review of Insurance Claims Data	5
Restrictive resuscitation in patients with sepsis and mortality: A systematic review and meta‐analysis with trial sequential analysis	5
Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired renal function and those requiring hemodialysis	5
Use of Remdesivir in Myasthenia gravis and COVID‐19	5
Comparative effectiveness of early‐targeted use of fidaxomicin versus oral vancomycin among hospitalized veterans’ affairs patients with infections due to Clostridioides difficile	5
Early clinical trial data and real‐world assessment of COVID‐19 vaccines: Insights from the Society of Infectious Diseases Pharmacists	5
Impact of Hospitalization and Medication Switching on Post‐discharge Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation	5
Complementary Use of U.S. FDA’s Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants‐Associated Cutaneous Small Vessel Vasculitis	5
The safety of rapid infusion levetiracetam: A systematic review	5
Precision fluid and vasoactive drug therapy for critically ill patients	5
Machine learning to predict vasopressin responsiveness in patients with septic shock	5

Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta‐analysis	5
Risks and mitigation strategies to prevent etoposide infusion‐related reactions in children	5
Quality of Evidence Supporting Major Psychotropic Drug‐Drug Interaction Warnings: A Systematic Literature Review	5
Evaluation of anti‐factor Xa concentrations using a body mass index‐based enoxaparin dosing protocol for venous thromboembolism prophylaxis in trauma patients	5
Predictive Validity of a QTc Interval Prolongation Risk Score in the Intensive Care Unit	5
Administration of rabies immunoglobulin: Improving evidence‐based guidance for wound infiltration	5
International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy	5
Antidepressant Target Dose Optimization and Control of Severe Asthma Exacerbations in Uninsured and Underinsured Patients with Anxiety and/or Depression	5
Renin‐angiotensin‐aldosterone system inhibitors and major cardiovascular events and acute kidney injury in patients with coronary artery disease	5
Evaluation of Guideline Recommendations for Dual Antipseudomonal Therapy in Hospitalized Adults with Pneumonia Using Combination Antibiograms	5
Pharmacogenetics of P2Y12 receptor inhibitors	5
Role of the gut microbiome in cardiovascular drug response: The potential for clinical application	4
Performance of different body weights in the Cockcroft‐Gault equation in critically ill patients with and without augmented renal clearance: A multicenter cohort	4
Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibitor combination targeting carbapenem‐resistant Acinetobacter baumannii infections	4
Extracorporeal treatments for isoniazid poisoning: Systematic review and recommendations from the EXTRIP workgroup	4
Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients	4
Incidence of viral and fungal complications after utilization of alternative donor sources in hematopoietic cell transplantation	4
Implications for body weight extremes in solid organ transplantation	4
Association of GGH Promoter Methylation Levels with Methotrexate Concentrations in Chinese Children with Acute Lymphoblastic Leukemia	4
Comparative effectiveness and safety of high‐dose rivaroxaban and apixaban for atrial fibrillation: A propensity score‐matched cohort study	4
Management of noncytotoxic extravasation injuries: A focused update on medications, treatment strategies, and peripheral administration of vasopressors and hypertonic saline	4
Use of therapeutic drug monitoring to characterize cefepime‐related neurotoxicity	4
Time to defervescence evaluation for extended‐ vs. standard‐infusion cefepime in patients with acute leukemia and febrile neutropenia	4
Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction	4
Tacrolimus time in therapeutic range and long‐term outcomes in heart transplant recipients	4
Impact of Incremental Delays in Appropriate Therapy on the Outcomes of Hospitalized Adult Patients with Gram‐negative Bloodstream Infections: “Every day matters”	4
Non‐steroidal Anti‐inflammatory Drugs and the Risk of Pneumonia Complications: A Systematic Review	4
Acute Graft‐versus‐Host Disease: Emerging Insights and Updates into Detection, Prevention, and Treatment	4
Prophylaxis for Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease: A systematic review	4
Choice of Acid Suppressant Therapy and Long‐Term Graft Outcomes After Kidney Transplantation	4
Vancomycin plus ceftaroline for persistent methicillin‐resistant Staphylococcus aureus bacteremia	4
Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus	4
A pharmacogenetic precision medicine approach to analgesia and sedation optimization in critically ill adults	4
COVID‐19: Important Therapy Considerations and Approaches in this Hour of Need	4
Anticoagulation strategies in patients with extracorporeal membrane oxygenation: A network meta‐analysis and systematic review	4
U.S. trends in prescription nonsteroidal anti‐inflammatory drug use among patients with cardiovascular disease, 1988–2016	4
Efficacy of risdiplam in spinal muscular atrophy: A systematic review and meta‐analysis	3
Effects of aging on clinical outcomes in patients receiving genotype‐guided P2Y12 inhibitor selection after percutaneous coronary intervention	3
Successful Treatment of Delayed Methotrexate Clearance Using Glucarpidase Dosed on Ideal Body Weight in Obese Patients	3
Elbasvir/grazoprevir administered for 12 weeks via percutaneous endoscopic gastrostomy tube achieves sustained virologic response: A case report and a review of the literature	3
Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and Inter	3
A systematic review of direct acting antiviral therapies in hepatitis C virus‐negative liver transplant recipients of hepatitis C‐viremic donors	3
Population Pharmacokinetic Study of Vancomycin in Chinese Pediatric Patients with Hematological Malignancies	3
Examining the clinical impact of rapid multiplex polymerase chain reaction‐based diagnostic testing for bloodstream infections in a national cohort of the Veterans Health Administration	3
Efficacy of inactivated vaccines in patients treated with immunosuppressive drug therapy	3
Comparison of catheter‐related bloodstream infection rates in pediatric patients receiving parenteral nutrition with soybean oil‐based intravenous fat emulsion versus a mixed oil fat emulsion	3
Considerations and controversies of pharmacologic management of the pediatric kidney transplant recipient	3
Comparison of nimodipine formulations and administration techniques via enteral feeding tubes in patients with aneurysmal subarachnoid hemorrhage: A multicenter retrospective cohort study	3
A systematic review of clozapine‐associated inflammation and related monitoring	3
Clinical and economic evaluation of a surveillance protocol to manage hepatitis B virus (HBV) reactivation among lymphoma patients with resolved HBV infection receiving rituximab	3
Risk of parkinsonism and related movement disorders with gabapentinoids or tramadol: A case‐crossover study	3
Chemotherapy‐associated cardiomyopathy: Mechanisms of toxicity and cardioprotective strategies	3
Norepinephrine reuptake inhibitors and risk of antihypertensive treatment intensification and major adverse cardiovascular events in patients with stable hypertension and depression	3
Optimizing rapid diagnostics and diagnostic stewardship in Gram‐negative bacteremia	3
Use of hormonal contraceptives in perimenopause: A systematic review	3
The impact of pretransplant opioid exposure on healthcare utilization and costs in kidney transplant	3
Alemtuzumab clearance, lymphocyte count, and T‐cell chimerism after hematopoietic stem cell transplant in sickle cell disease	3
The Cardiovascular Effects of Treatment with Hydroxychloroquine and Azithromycin	3
Vancomycin Area Under the Curve‐guided Dosing and Monitoring: “Is the Juice Worth the Squeeze”?	3
Impact of timing and dosing of four‐factor prothrombin complex concentrate administration on outcomes in warfarin‐associated intracranial hemorrhage	3
Colchicine for Secondary Cardiovascular Prevention: A Systematic Review	3
The immunomodulatory effects of opioids and implications for intensive care unit populations	3
Management of diffuse alveolar hemorrhage in the hematopoietic stem cell transplantation population: A systematic review	3
Dexmedetomidine for prevention of opioid/benzodiazepine withdrawal syndrome in pediatric intensive care unit: Interim analysis of a randomized controlled trial	3
Effects of Co‐administration of Sulfonylureas and Antimicrobial Drugs on Hypoglycemia in Patients with Type 2 Diabetes Using a Case‐Crossover Design	3
Reduced risk of NSAID‐Induced adverse events with concomitant use of misoprostol (MICRO study)	3
Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies	3
Contribution of pharmaceutical drugs of dependence to the incidence of neonatal abstinence syndrome in Western Australia between 2003 and 2018	3
Comprehensive guidance for antibiotic dosing in obese adults: 2022 update	3
NONMEM population pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life‐threatening severe infections during support with or without extracorporeal membr	3
Beyond Heart Failure and Ischemic Heart Disease: A Scoping Review of Novel Uses of Ivabradine in Adults	3
Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic‐pharmacodynamic model	3
Insulin NPH for steroid‐induced hyperglycemia: Predictors for success	3
Use of naldemedine is associated with reduced incidence of hyperactive delirium in cancer patients with opioid‐induced constipation: A nationwide retrospective cohort study in Japan	3
Effects of GLP‐1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and meta‐analysis	3
Management of noncardiovascular comorbidities in patients with heart failure with reduced ejection fraction	3
Maintenance Strategies After Hematopoietic Cell Transplantation	2
Population pharmacokinetics of linezolid and its major metabolites PNU‐142300 and PNU‐142586 in adult patients	2
Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population‐based propensity score‐matched cohort study	2
Characterization of antiplatelet response to low‐dose cangrelor utilizing platelet function testing in neuroendovascular patients	2
High prescribing of antibiotics is associated with high prescribing of opioids in medical and dental providers	2
Path of least recurrence: A systematic review and meta‐analysis of fidaxomicin versus vancomycin for Clostridioides difficile infection	2
Outcomes of adult patients in the intensive care unit with Pseudomonasaeruginosa pneumonia who received an active anti‐pseudomonal β‐lactam: Does “S” equal success in the presence of res	2
Performance of nasal methicillin‐resistant Staphylococcus aureus screening for intra‐abdominal infections in critically ill adult patients	2
A propensity score‐matching analysis of angiotensin‐converting enzyme inhibitor and angiotensin receptor blocker exposure on in‐hospital mortality in patients with acute respiratory failure	2
New ways of using old antibiotics in pediatrics: Focus on fosfomycin	2
Randomized controlled trial to compare safety and efficacy of mycophenolate vs. cyclosporine after rituximab in children with steroid‐resistant nephrotic syndrome	2
Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation	2
Renal function estimating equations performance during pregnancy and postpartum	2
The effect of antipsychotic treatment on hormonal, inflammatory, and metabolic biomarkers in healthy volunteers: A systematic review and meta‐analysis	2
Is ketamine infusion effective and safe as an adjuvant of sedation in the PICU? Results from the Ketamine Infusion Sedation Study (KISS)	2
Characterization of Risk Factors for Genitourinary Infections with Sodium‐Glucose Cotransporter‐2 Inhibitors	2
Hydroxyurea for children with sickle cell disease in sub‐Saharan Africa: A summary of the evidence, opportunities, and challenges	2
Drug repurposing of dextromethorphan as a cellular target for the management of influenza	2
Current pharmacotherapy management of children and adults with pericarditis: Prospectus for improved outcomes	2